Skip to main navigation Skip to search Skip to main content

Effects of teriflunomide (Aubagio) on gray matter pathology in multiple sclerosis - a 12 months, prospective, observational, single-blinded, longitudinal study

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/13 → 06/30/16

Funding

  • Genzyme Corporation: $469,790.00